Skullcap Safety: Germander Adulteration and Liver Injury

This is the page about skullcap that most sources leave out, and it is the one that changes what you should actually do. American skullcap (Scutellaria lateriflora, aerial parts) acquired a reputation for causing liver damage from a handful of case reports published decades ago. Investigation of those reports produced a striking finding: a number of commercial products sold as “skullcap” had been substituted with germander (Teucrium species), a different plant that is genuinely and mechanistically hepatotoxic, and which caused a well-documented cluster of liver-injury cases in France that led to its withdrawal from sale there in 1992.

It is tempting to use that finding as reassurance — “it wasn't the skullcap” — and that is exactly the wrong lesson to take from it. The attribution cuts in both directions. It does partly exonerate the herb itself. It also means that the risk was real, that it travelled inside bottles labelled skullcap, and that the only thing separating a safe product from a dangerous one was whether anybody had verified what was in it. A herb whose safety depends entirely on supply-chain integrity is not the same as a herb that is simply safe. This page explains the toxicology honestly, then explains what a reader can actually do about it.

Why This Is the Page That Matters
What Germander Is
How Germander Damages the Liver
The French Cluster and the Withdrawal
How Germander Ended Up in Skullcap
The Skullcap-Labelled Case Reports
What the Attribution Does and Does Not Prove
Chinese Skullcap's Separate Liver Signal
How Plant Identity Is Actually Verified
Buying Skullcap: A Practical Checklist
Recognising Liver Injury
Who Should Avoid Skullcap Entirely
The Broader Lesson
Key Research Papers
Connections

Why This Is the Page That Matters

Most of what is written about skullcap concerns benefits with modest evidence behind them: a small randomized trial or two for anxiety, tradition for sleep, and a large volume of laboratory work that belongs to a different species. The potential upside of taking the herb is therefore real but small.

The adulteration story is different in kind. Severe liver injury is a low-probability event, but it is a high-consequence one — germander hepatitis in the French cluster included cases that progressed to serious liver failure. When an intervention offers a modest benefit and carries a small chance of a severe harm, the harm side deserves the greater share of your attention, and the mitigation — buying an authenticated product — is cheap and completely within your control. That asymmetry is why this page exists and why it is placed alongside the benefits rather than buried in a footnote.

What Germander Is

Evidence tier: botany and regulatory history.

Germander is the common name of Teucrium, a genus of well over two hundred species distributed mainly around the Mediterranean and across western Asia. Two matter here:

Teucrium chamaedrys, wall germander — the species at the centre of the French hepatitis cluster. A low, woody, small-leaved plant traditionally used as a bitter tonic and, more recently, marketed in capsules and infusions as a slimming aid.
Teucrium polium, felty germander — widely used in traditional medicine across the Middle East and North Africa, and independently implicated in liver-injury reports from that region (PubMed search). The problem is not confined to one species.

The detail that makes the substitution possible is taxonomic proximity. Teucrium and Scutellaria are both members of the mint family, Lamiaceae. Both are low herbaceous plants with square stems, opposite paired leaves, small toothed leaf margins and small two-lipped flowers. Neither has a strong distinguishing aroma once dried. Reduced to a bag of crumbled grey-green leaf, they are not easy to tell apart by eye — and reduced to a powder inside a capsule, they are impossible.

How Germander Damages the Liver

Evidence tier: mechanistic animal and cell studies, unusually well worked out for a herbal toxin.

Germander is not vaguely “bad for the liver.” Its toxicology has been characterised in a way that few herbal safety questions ever are, and the mechanism is worth understanding because it explains why the injury can be severe and why some people are affected while others are not.

The culprits are a class of compounds called neoclerodane diterpenes, of which teucrin A is the best studied. These molecules carry a furan ring, and a furan ring is a classic structural alert in toxicology: it is chemically unremarkable until an enzyme oxidises it, at which point it becomes a highly reactive electrophile. The sequence runs roughly as follows:

Bioactivation. Cytochrome P450 enzymes in the liver — principally the CYP3A subfamily — oxidise the furan ring of teucrin A and its relatives to a reactive epoxide-type metabolite. The parent compound is comparatively harmless; the liver creates the poison in the act of trying to clear it.
Glutathione depletion. Reactive metabolites are mopped up by glutathione. Sustained exposure exhausts that defence, and once glutathione falls the reactive species reach their targets.
Protein adduct formation. The metabolites bind covalently to cellular proteins, including thiol groups on cytoskeletal proteins. Rat-hepatocyte work described loss of cytoskeleton-associated protein thiols and formation of membrane blebs — a visible sign that the cell's structural scaffolding is failing (PubMed search).
Cell death. The result in animal models is apoptosis and necrosis of hepatocytes, corresponding clinically to a hepatocellular pattern of injury with markedly raised transaminases.
Possible immune involvement. Protein adducts can also act as neo-antigens, and some germander cases showed features suggesting an immune component, which would help explain why injury recurred rapidly on re-exposure in some patients.

The two foundational animal papers are Hepatotoxicity of germander (Teucrium chamaedrys L.) and one of its constituent neoclerodane diterpenes teucrin A in the mouse (Chemical Research in Toxicology, 1994; PubMed search) and Hepatotoxicity of germander in mice (Gastroenterology, 1994; PubMed search).

Three practical consequences follow from this mechanism. First, the dose and duration matter, because the injury depends on outrunning glutathione. Second, anything that induces CYP3A or depletes glutathione could plausibly worsen it — which includes alcohol, fasting, and a number of medications. Third, susceptibility varies between individuals, which is why a cluster of cases can emerge from a product that thousands of other people took without apparent harm. That last point is the reason absence of reported harm is weak evidence of safety.

The French Cluster and the Withdrawal

Evidence tier: clinical case series and regulatory action.

In the late 1980s germander was being sold in France in capsules and teas, largely as a slimming aid — a use with no evidence behind it, taken by otherwise healthy people, often for weeks or months. Hepatologists began seeing hepatitis in patients whose only common exposure was this product. The pivotal report, Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity, appeared in Annals of Internal Medicine in 1992 (PubMed search).

The clinical picture reported in that literature had several features that made causation persuasive rather than merely suspected:

A consistent hepatocellular pattern — jaundice with markedly elevated transaminases, appearing after weeks to months of use.
Improvement on stopping the product in most patients, the single most informative observation in drug-induced liver injury.
Recurrence, sometimes faster and more severe, on re-exposure in patients who resumed the product — the closest thing to a natural experiment that clinical toxicology gets, and strong evidence of causation.
Serious outcomes in a minority, including progression toward liver failure, which is what moved this from a curiosity to a regulatory matter.
Absence of an alternative explanation after investigation for viral hepatitis, autoimmune disease and alcohol.

French authorities withdrew germander from sale in 1992. The episode became a standard teaching case in hepatology for herbal hepatotoxicity, and it is why germander appears in reference works on drug and herb-induced liver injury such as LiverTox, hosted on the NCBI Bookshelf. Reviews of hepatotoxic slimming products and other herbal liver toxins routinely include it (PubMed search).

How Germander Ended Up in Skullcap

Evidence tier: quality-control analyses and pharmacopoeial monographs.

Substitution of one dried herb for another does not require a conspiracy. Several ordinary pressures produce it:

Morphological similarity. As described above, dried Teucrium and dried Scutellaria leaf are genuinely hard to distinguish, and both lack a diagnostic smell.
Wild collection and long supply chains. Skullcap has historically been wild-harvested. Material can pass through collectors, aggregators, brokers, exporters and repackagers before reaching a manufacturer, and identity claims are inherited at each step rather than re-tested.
Price and scarcity. When authentic material is expensive or in short supply, a cheaper look-alike becomes attractive somewhere along that chain.
Common names as a failure point. Herb trading has often used common names, which are ambiguous across regions and languages. A binomial travels; a folk name does not.
Powdering and encapsulation destroy the evidence. Once material is milled, the botanical features a trained eye would use are gone. Capsules and multi-herb blends are therefore where adulteration is least detectable.

This is not speculative reconstruction. Identity and adulteration are treated as central concerns in the American Herbal Pharmacopoeia monograph Skullcap Scutellaria lateriflora L.: an American nervine (Journal of Herbal Medicine, 2012; PubMed search) and examined directly in Identity issues surrounding American skullcap (Scutellaria lateriflora) and the potential for adulteration (Journal of Herbal Medicine, 2013; PubMed search). Beyond germander, the same literature notes substitution with other Scutellaria species such as S. galericulata — less dangerous, but still not the herb the label claims.

The Skullcap-Labelled Case Reports

Evidence tier: clinical case reports, with attribution that is reasoned rather than proven.

The reports that gave skullcap its reputation date largely to the late 1980s and after. Hepatotoxicity of herbal remedies in the BMJ in 1989 (PubMed search) described liver injury in patients taking herbal products that included skullcap, commonly in combination with valerian. Additional scattered reports followed. Skullcap consequently appears on lists of herbs associated with hepatotoxicity, and it is fair to say the association exists in the literature.

What that association can and cannot establish deserves care, because case reports of multi-ingredient herbal products are among the weakest forms of causal evidence available:

Multiple ingredients. When a product contains several herbs, a case report implicates the product, not a component. Attribution to skullcap specifically was an inference.
The material was rarely analysed. In most reports the actual product was not chemically or botanically tested, so nobody knows what the patient took. Where analysis was possible, germander was found in some skullcap-labelled material — which is the origin of the reattribution.
Clinical presentation fits germander. The pattern in the skullcap-labelled cases resembled the well-characterised germander picture, which strengthens the substitution hypothesis without proving it in any individual case.
No mechanism has been established for skullcap itself. Unlike germander's furan-diterpene bioactivation, there is no known hepatotoxic constituent or mechanism identified in S. lateriflora. Absence of a known mechanism is not proof of safety, but it is a meaningful asymmetry between the two plants.

What the Attribution Does and Does Not Prove

This section is the crux, because the germander explanation is routinely deployed as reassurance and that use of it is not honest.

What it legitimately supports:

Correctly identified S. lateriflora aerial parts have no established hepatotoxic constituent and no demonstrated mechanism of liver injury.
The old “skullcap damages the liver” claim, stated flatly, is probably wrong as a statement about the plant.
A substantial part of the historical risk was a supply-chain failure and is therefore addressable rather than intrinsic.

What it does not support:

It does not clear any particular bottle. The exonerating argument applies to the plant, and only to products that actually contain the plant. You cannot verify that yourself from the label alone.
It does not prove skullcap has never caused liver injury. Most reported cases were never analysed, so some may genuinely have involved authentic material. The correct statement is that skullcap-labelled products have been associated with liver injury and that germander substitution is the leading explanation — not that skullcap is definitively innocent.
It does not mean the risk is historical. Botanical adulteration remains an active concern across the supplement market, which is why organisations such as the American Botanical Council run ongoing adulterants-prevention programmes. The problem is monitored because it has not gone away.
It does not make identity optional. If the safety of a product rests on it containing what it says, then verification is the safety measure, not a nicety.

The correct posture is therefore neither the old alarm nor the modern brush-off. It is: this herb is probably benign, the marketplace is the risk, and you reduce that risk by buying material whose identity someone has actually tested.

Chinese Skullcap's Separate Liver Signal

Evidence tier: clinical case series and clinical review.

A reader who has absorbed the germander story sometimes concludes that all skullcap liver concerns are impostor problems. They are not, and the other species has a distinct issue where the implicated ingredient is the herb itself.

Chinese skullcap root (Scutellaria baicalensis) and its flavone baicalin appear in the herbal hepatotoxicity literature. The clearest example is the flavocoxid preparations, marketed for osteoarthritis and combining baicalin from S. baicalensis with catechins from another plant; a case series of acute liver injury attributed to that product was published in Annals of Internal Medicine in 2012 (PubMed search). Scutellaria baicalensis is also among the botanicals discussed in Liver injury from herbal and dietary supplements (Hepatology, 2017; PubMed search), a clinical review drawing on prospective registry data.

Three points keep this in proportion. The signal involves concentrated modern preparations more than traditional formula-level doses; the herb is consumed on an enormous scale in East Asia, so the absolute risk per user must be low; and, as noted on the baicalin page, baicalin has paradoxically been reported to protect rodent livers in model systems — a reminder that animal protection data cannot be used to reassure anyone about a human safety signal. The practical upshot is simply that “skullcap” on a label may be either species, and both have a liver question, for different reasons.

How Plant Identity Is Actually Verified

Knowing what the verification looks like helps you judge whether a manufacturer's claim means anything.

Macroscopic and organoleptic examination. A trained analyst inspects whole or coarsely cut material against a monograph description — leaf shape and margin, stem cross-section, flower structure, colour, taste. Cheap and effective on whole herb, useless on powder.
Microscopy. Cellular features such as trichome type and epidermal patterning survive milling and can distinguish related genera. This is the classical pharmacognosy method and it is still valuable.
Chromatographic fingerprinting. Thin-layer chromatography or HPLC produces a pattern of constituent peaks compared against an authenticated reference. For this specific problem it is powerful, because the relevant marker is unambiguous: teucrin A and related neoclerodane diterpenes should be entirely absent from genuine skullcap. A test that looks for the adulterant's marker rather than only for the target herb's markers is the stronger design.
DNA barcoding. Sequencing standard marker regions identifies the species from which the material came, and works even on powder. It has limits — DNA degrades in highly processed extracts, and it identifies species without quantifying how much of each is present — so it complements rather than replaces chemistry.
Documented chain of custody. Records tying a finished batch back to a specific harvest, with certificates of analysis at each transfer. Unglamorous, and the thing that actually prevents substitution rather than merely detecting it.

Independent programmes exist because none of this happens by default: the American Botanical Council co-runs a botanical adulterants prevention programme publishing bulletins on specific herbs, while USP and NSF operate supplement verification schemes. Note carefully what such marks do and do not certify: they address identity, purity and manufacturing quality — not whether the herb works. In the United States, dietary supplements are not approved for safety or efficacy before sale; the FDA acts largely after problems appear.

Buying Skullcap: A Practical Checklist

Concretely, in rough order of importance:

Insist on the binomial and the plant part. “Scutellaria lateriflora, aerial parts” for the nervine; “Scutellaria baicalensis, root” for the Chinese herb. A product that says only “Skullcap” should be put back on the shelf.
Prefer whole or coarsely cut dried herb over powder and capsules where practical. Visible plant material can be inspected and smelled; powder cannot. This single choice removes the conditions under which the historical substitution went unnoticed.
Favour makers who state that identity was tested, and who will supply a certificate of analysis on request. A company that cannot answer “how do you verify the species?” has told you something useful.
Look for third-party verification as a proxy for manufacturing discipline, remembering it says nothing about efficacy.
Be extra sceptical of multi-herb blends and “proprietary formulas.” Every extra botanical is another identity risk, and undisclosed amounts make both dose and interaction assessment impossible.
Avoid weight-loss and “detox” products entirely. Germander's own disaster happened in a slimming product, and that category has produced a disproportionate share of herbal liver injury generally.
Do not buy unlabelled bulk herb from unfamiliar sources. Loose-leaf material with no species name and no provenance is exactly the material that caused the problem.
Keep the packaging while you are taking it. If something goes wrong, the batch number and the actual product are what allow a clinician or regulator to investigate.

Recognising Liver Injury

Herb-induced liver injury is uncommon, and it is also easy to miss early because the first symptoms are unremarkable. Stop the product and seek medical attention for:

Unusual, persistent fatigue — frequently the earliest and most easily dismissed sign.
Loss of appetite, nausea, or vomiting.
Discomfort or aching in the right upper abdomen.
Dark, tea-coloured urine and pale or clay-coloured stools.
Yellowing of the skin or the whites of the eyes (jaundice) — a clear signal requiring prompt assessment.
Itching without a rash.
Easy bruising, or confusion and drowsiness — features of advanced impairment and a medical emergency.

Two things help a clinician enormously: stopping the suspected product immediately, and bringing the actual bottle rather than a description of it. Diagnosis rests on blood tests, so see Liver Function Tests for what ALT, AST, alkaline phosphatase and bilirubin indicate, and Liver Disease for the broader picture. Also tell the clinician about every supplement, not just the one you suspect — herb-induced liver injury is frequently missed because patients do not think of supplements as drugs.

Who Should Avoid Skullcap Entirely

Anyone with existing liver disease of any kind — hepatitis, cirrhosis, fatty liver disease, or unexplained abnormal liver tests. The margin for error is smaller and the upside does not justify it.
Anyone who has had a previous drug- or herb-induced liver injury.
People taking medications with known liver toxicity or narrow safety margins — certain antibiotics, antifungals, antiepileptics, methotrexate, isoniazid, high-dose paracetamol, among others. Ask a pharmacist.
Heavy alcohol users. Alcohol induces CYP2E1, stresses the liver and depletes glutathione, all of which point the wrong way.
Pregnant and breastfeeding women. Insufficient safety data for either species.
Children, other than under clinician guidance, despite the traditional claim of gentleness.
Anyone facing surgery, who should stop calming herbs well in advance and disclose them to the anaesthetist.
Anyone who cannot confirm what species the product contains. That is not a fussy preference — on the evidence above, it is the whole safety question.

The Broader Lesson

The germander–skullcap episode is a small story that carries a large and uncomfortable general point: a herb can be gentle and still harm you, if what is in the container is not what the label says. Efficacy and safety are both properties of an actual product, not of a plant name. In a market where premarket verification is not required, the label is a claim rather than a guarantee.

Four transferable habits:

Botanical name and plant part, always. Common names are ambiguous and ambiguity is where substitution lives.
Treat processing as a loss of information. Whole herb can be checked; extract powder in a capsule must be trusted.
Weigh benefit against harm honestly. Where the benefit is modest and human evidence is thin, even a small chance of severe harm should dominate the decision.
Tell clinicians about supplements. They cannot connect an unexplained hepatitis to a herbal tea nobody mentioned.

The point of all this is not to frighten anyone away from a mild traditional tea. It is that the one genuinely important thing to know about skullcap is a supply-chain fact rather than a pharmacological one — and that is unusual enough to be worth a page of its own.

Key Research Papers

Each entry links a PubMed topic search rather than a fixed record, with the paper identified by title, journal and year where known, and an explicit evidence tier.

Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity. Annals of Internal Medicine, 1992. The pivotal French clinical series, including improvement on withdrawal and recurrence on re-exposure. Clinical case series. PubMed search
Hepatotoxicity of germander (Teucrium chamaedrys L.) and one of its constituent neoclerodane diterpenes teucrin A in the mouse. Chemical Research in Toxicology, 1994. Identifies teucrin A as a hepatotoxic constituent. Animal toxicology. PubMed search
Hepatotoxicity of germander in mice. Gastroenterology, 1994. Dose-dependent hepatocellular injury and the role of metabolic activation. Animal toxicology. PubMed search
Metabolic activation of germander furano diterpenoids by cytochrome P450 3A, with depletion of cytoskeleton-associated protein thiols and membrane bleb formation in hepatocytes. Hepatology, mid-1990s. The cellular mechanism of injury. Cell and animal mechanism. PubMed search
Hepatotoxicity of herbal remedies. BMJ, 1989. Liver injury in patients taking skullcap-containing herbal products — the reports that created skullcap's reputation. Clinical case reports, multi-ingredient products. PubMed search
Identity issues surrounding American skullcap (Scutellaria lateriflora) and the potential for adulteration. Journal of Herbal Medicine, 2013. Direct examination of substitution risk in commercial skullcap. Quality-control analysis. PubMed search
Skullcap Scutellaria lateriflora L.: an American nervine. Journal of Herbal Medicine, 2012. The American Herbal Pharmacopoeia monograph, treating identity and authentication as central. Monograph review. PubMed search
Acute liver injury due to flavocoxid (Limbrel), a medical food for osteoarthritis: a case series. Annals of Internal Medicine, 2012. The Chinese-skullcap side of the liver story, where the implicated ingredient is the herb itself. Clinical case series. PubMed search
Liver injury from herbal and dietary supplements. Hepatology, 2017. Clinical review drawing on prospective registry data, placing Scutellaria in context. Clinical review. PubMed search
Liver injury associated with Teucrium polium in traditional use across the Middle East and North Africa — evidence that the problem is a genus property, not one product. Clinical case reports. PubMed search
Reviews of hepatotoxic slimming aids and other herbal hepatotoxins, in which germander is a standard example. Clinical review literature. PubMed search
DNA barcoding and chromatographic authentication of herbal raw materials, including detection of substituted species in botanical supplements. Analytical methodology. PubMed search
Causality assessment in herb-induced liver injury — how clinicians decide whether a supplement caused a hepatitis, and why multi-ingredient products are so hard to adjudicate. Clinical methodology. PubMed search

External Resources

NCBI Bookshelf — hosts LiverTox, the NIH reference on drug and herbal liver injury, with entries for germander and for skullcap.
National Institute of Diabetes and Digestive and Kidney Diseases — liver disease information and the LiverTox programme.
NIH National Center for Complementary and Integrative Health — herb safety summaries.
U.S. Food and Drug Administration — supplement regulation and adverse-event reporting.
American Botanical Council — botanical adulterants prevention programme bulletins.
United States Pharmacopeia and NSF International — independent supplement verification.
MedlinePlus — plain-language information on liver symptoms and tests.

Back to Table of Contents

Connections

Safety and disclaimer. This page is educational and is not medical advice or a diagnostic tool. Germander (Teucrium species) is hepatotoxic and should not be taken deliberately in any form. American skullcap (Scutellaria lateriflora, aerial parts) has no established hepatotoxic constituent, but skullcap-labelled products have been associated with liver injury and germander substitution is the leading explanation — which makes verified product identity the single most important safety step, not an optional refinement. Chinese skullcap root (Scutellaria baicalensis) carries its own separate liver-injury signal. Avoid either species if you have liver disease, a history of drug- or herb-induced liver injury, or heavy alcohol use; avoid in pregnancy and breastfeeding; do not combine with sedatives or alcohol; discontinue before surgery; and consult a pharmacist about interactions with prescription medication. Stop any herbal product and seek prompt medical attention for unusual fatigue, nausea, right-upper-abdominal pain, dark urine, pale stools, itching, or yellowing of the skin or eyes — and bring the actual product with you.

Back to Table of Contents